The intestinal microbiota, which consists of a diverse community of gut-resident microbes, tightly coevolves with the mammalian immune system. Even at birth, the microbes inhabited in gut have begun to shape the development of immune system. In turn, the innate and adaptive immune responses constantly and dynamically maintain the intestinal homeostasis by keeping these resident microbes in their proper position. Mining the complex relationships between the intestinal microbiota and the host immunity will benefit to understanding of the mucosal immune system orchestration and developing of novel diagnostic/therapeutic approaches for treating intestinal inflammatory disorders such as infectious diseases in human. In recent years, new technologies, e.g., next-generation sequencing, gnotobiotic animal models, improved-anaerobic culture of bacteria, etc., have been developed and applied to the area of microbiota research. With the advantage of these technologies, we now achieve more in-depth understanding of the interplay between the mucosal immune system and the commensals, especially, of the induction of T helper 17 (Th17) and regulatory T (Treg) cells by different bacteria in human gut. In this review, I will highlight recent progresses, which are largely promoted by the technological advances, on how gut microbiota instructs the Th17/Treg cells development in the intestine.
Introduction
The human body is inhabited by complex microbial communities which include bacteria, archaea, viruses, fungi as well as protists and metazoans. The collection of such symbiotic communities is called microbiota or microflora, among which, the functional roles of bacteria are most extensively studied. It is estimated that the human microbiota includes a composition of 10 14 bacterial cells, which is 10-fold of the number of human cells in human bodies (1) . Moreover, these symbionts may express 100-fold more unique genes than the human genome (1) . The microbiota colonizes nearly every surface of the human body, e.g., skin, respiratory tracts, gastrointestinal tracts, etc. To date, the gastrointestinal tract is the most heavily colonized organ in our body, and especially, the colon itself is estimated to harbor more than two-thirds of all the resident bacteria (1) . The human intestinal microbiota is mainly dominated by two phyla of bacteria: the Bacteroidetes and the Firmicutes (1, 2) . It also contains several minor populations such as Actinobacteria, Proteobacteria, Verrucomicrobia, Fusobacteria, Cyanobacteria, Tenericutes, and Deferribacteres (1, 2) . The composition of intestinal bacterial species or strains highly varies between individuals, but in general, it is estimated that it contains a few hundred to several thousand species or strains in our gut (1, 2) . In addition, the intestinal microbiota is heterogeneous in different anatomic locations, e.g., small intestine vs colon or lumen vs mucosal surface (2) . The microbes immediately colonize human gut at birth and the composition of these microbes is similar to that of maternal vaginal microbiota if the infant is vaginally delivered adaptive immune responses not only by recognizing the types of microbes but also by producing distinct cytokines (8) . Briefly, antigen-presenting cells (APCs), such as phagocytes, produce IL-12 to enhance T helper 1 (Th1) response. Alternatively, those cells release IL-6 and IL-23 for Th17 cell development. Epithelial cells produce IL-25, IL-33, and TSLP to induce Th2 immunity in response to parasites or allergens. More recently, a group of previously less characterized innate immune cells, called innate lymphoid cells (ILCs), has also been shown to be induced by these cytokines (9) . ILC1s, ILC2s, and ILC3s represent the innate subsets with similar development programs to Th1, Th2, and Th17 cells respectively (9) . Both T cells and ILCs are critical for host defense responses to distinct intestinal pathogens (9) . Th1 cells and ILC1s release effector cytokine IFN-γ for host anti-intracellular pathogen responses. Th2 cells and ILC2s produce type 2 cytokines such as IL-4, IL-5, and IL-13 for worm expulsion and tissue repairing. Th17 cells and ILC3s produce signature cytokines IL-17 and IL-22 for promoting host anti-microbial responses to extracellular pathogens and fungi. However, how gut microbiota tunes the intestinal immune system against pathogens remains obscured. In this review, I will highlight the latest technological advances in microbiota research and summarize recent progresses on how these microbes orchestrate protective T cell responses in the intestine.
Mining the intestinal microbiota
Over the years, researchers have only studied microorganisms by microscopic observation and low-efficient culture technologies in petri plates. Counts of bacterial cells observed from petri plates are often less than 1% of those directly counted under a microscope. This orders of magnitude gap, which is known as 'The Great Plate Count Anomaly', obviously compromises many ecological studies of microbial community including the study of human gut microbiota. Methodological innovations such as fingerprinting techniques or Sanger sequencing enable us to access the uncultivable part of environmental microbes. However, the imprecision of fingerprinting techniques and the low efficiency, high cost of Sanger sequencing still impede the community-wide studies of microbes. Until the emergence of high-throughput next-generation sequencing technology, investigation of multitudinous microbial communities such as intestinal microbiota has become practicable and cost-effective.
In recent years, the next-generation sequencing technology becomes an extremely powerful tool to study the gut symbiotic communities. Different sequencing platforms have been developed for culture-independent microbiome research, including Roche 454 GS FLX(+), Illumina GA/ HiSeq/MiSeq/NextSeq, Applied Biosystems SOLiD, Ion Torrent personal genome machine/proton, and PacBio RS (10) . In addition, many bioinformatic tools such as QIIME and mothur programs were accordingly developed in favor of analyzing sequence data (11, 12) . The widest use of these sequencing technologies is to profile the composition of human gut microbiota by 16S rRNA gene amplicon sequencing. The 16S ribosomal RNA gene was present in all bacteria, and it contained both highly conserved and hypervariable regions which could be used to determine taxa diversity with relatively high precision (13) . Primers were designed and used to amplify the variable fragments of the 16 rRNA gene by PCR in a given DNA sample of the microbial community (13) . Thus, sequencing of these 16S rRNA gene amplicons can reflect the composition and proportion of the bacterial communities in a given sample. Similarly, fungal diversity could be determined by sequencing the 18S rRNA gene amplicons (14) .
However, 16S rRNA gene sequencing-based taxonomic profiling can only help us by telling which bacteria are in the community and its resolution is limited to species-level. Bacterial strains in certain species may display varied functions which cannot be detected by 16S rRNA gene sequencing. For examples, intestinal dysbiosis might cause outgrowth and mis-loclation of inflammatory E.coli which indirectly promoted colon cancer development by triggering inflammatory cytokines production in intestinal epithelial cells (15) , while E.coli strains with a genotoxic polyketide synthase (pks) island directly promoted intestinal tumorigenesis by eliciting DNA damage in intestinal epithelial cells (16) . More interestingly, as I will discuss below, a human gut commensal, Bacteroides fragilis, prevented us from intestinal inflammation by directing the generation of suppressive Treg cells in the gut (17) . However, enterotoxigenic Bacteroides fragilis (ETBF) strains of this commensal oppositely generated inflammatory Th17 responses to enhance carcinogenesis in the colon (18) . 'Omics' Techniques, such as shotgun DNA sequencing-based metagenomics which integrate functional genomic annotation and strain-level taxonomic profiling, greatly promoted our understanding of the functional potentials of gut microbiota with a high taxonomic resolution (19) . By categorizing sequence reads in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database or other databases, researchers were able to link a specific host phenotype to certain functional changes in whole microbial communities (20) . One 'classic' example for this approach was that, by metagenomics analysis of the gut microbiota between obese and lean mice, researchers showed that obese mice had an decreased ratio of Bacteroidetes to Firmicutes in their gut, and this compositional shift caused the enrichment of genes for energy harvest in the gut microbiome of these mice (21) . However, the limited number of annotated whole-genome reference sequences in databases largely impedes the association of gene sequences with their original genomes. To remedy this, in recent years, LEA-Seq, a high-fidelity, low-error 16S rRNA gene sequencing method, was developed and applied into the studies of gut bacterial composition in individuals at the strain-level precision (3) .
Other 'Omics' technologies, such as metatranscriptomics, metaproteomics, and metabolomics, are all integrated into microbiome study in recent years. The metagenomics analysis only gathers genomics information of a certain microbial community, while it cannot tell researchers which genes are actively transcribed. Indeed, one study showed that there was only 41% overlap between metagenomics and metatranscriptomics data, suggesting that metagenomics technology cannot fully achieve the goal for understanding what a microbial community is really doing in its niche (22) . Despite it was helpful for profiling functional microbial genes that are actively transcribed, metatranscriptomics provided only a snapshot of the dyna-mic interplays between microbial communities and their niches, as most microbial mRNAs were relatively instable (23) . Therefore, taking a look of post-transcriptional and translational regulation of microbial genes by metaproteomics might be a complement to metatranscriptomics study (24) . In addition, it was the fact that protein abundance was not always coupled with mRNA level in bacteria, thus metaproteomics might be a more accurate approach to characterize the functional potentials of a given microbial community (24, 25) . However, lacking of annotated microbial whole-genomes in databases was still impeding the interpretation of metatranscriptomics and metaproteomics data. An alternative approach for this situation was to study the microbiota metabolic functionality by metabolomics, which analyzed the bacteria-derived metabolites composition, rather than these of mRNAs and proteins, in a given microbial or host fluid or tissue samples (26) . In summary, integration of metagenomics with metatranscriptomics, metaproteomics, or metabolomics may favor a deeper understanding of interplay between host and microbes ( Figure 1 ).
Despite extremely powerful, 'omics' technologies often produce correlative but not causal evidence for a link between alternations of microbiome and host phenotypes. To complement this shortcoming, additional experimental methods such as gnotobiotic animal models and anaerobic culture of gut bacteria were developed to investigate whether an altered gut microbial community or its metabolites could be translated into a corresponding physiological or pathological phenotype in gnotobiotic animals (27, 28) . Gnotobiotic mice, also called germ-free (GF) mice, provide a complementary approach for surveying the functional properties of a given bacterium or microbial community. GF mice can be colonized with either a single bacterial strain or complex microbial community from donors including us. Once colonized, a specific phenotype, e.g., the induction of certain immune cell population or the change in host metabolism etc., can be evaluated to make a causal link between the restored bacterium/bacteria and the functional capacities it/they mediated. As I will discuss later, one 'classic' discovery was to identify segmented filamentous bacterium (SFB) as the inducer for Th17 cells in the gut by this approach (29) . However, it is not always the case that alteration of a single strain is causally responsible for a certain phenotype in host. In many cases, different bacteria may cooperatively contribute to a given phenotype in their host, thus we may test all combinations of bacteria for their ability to transmit such phenotype into GF mice. By transplantation of intact microbiota samples (e.g., human fecal samples) from donors of interest, we Figure 1 . Screening of immune-effector strains from intestinal microbiome by integrated-approaches. The first step of screening is to transplant intact fecal microbiota from human donors of interest to germ-free mice. The capacity of their gut microbial communities to induce a particular immune phenotype is tested in these recipient mice. A representative human donor microbiota, either directly from the donor or the recipient mice, is selected by the screening and subsequently cultured in arrayed-multiwell plates under anaerobic condition. The genome, transcriptome, proteome or metabolome of the intact microbiota or each cultured member can be determined by indicated high through-put 'omics' technologies. The cultivable strains are rationally designed or randomly assigned to different microbial combinations. Such combinations are then transplanted to recipient germ-free mice for assessing the immune phenotype of interest. Finally, a particular immune phenotype may be causally linked to a subset of microbes (the effector strains) by this narrow-down approach. Similarly, the corresponding microbial derived-metabolites etc. can be also administrated into recipient germ-free mice to evaluate their capacity for inducing a given immune phenotype.
can assess whether a transmitted phenotype is induced an indistinctive way or is highly donor-specific (28) . Then the cultivable components in a targeted intact microbiota samples are combined either randomly or intentionally to assess their effects on transmission of a given phenotype into GF mice (28) . This combinatorial screening approach may less biasedly identify the bacterial effector strains for a given phenotype. The obstacles for such approach are how to feasibly and cost-effectively test large numbers of combinations in germ-free isolators and how to increase the bacterial diversity by improved-anaerobic culture, as the more we can recover from the intact samples, the more chance we would like to identify the effector stains. To overcome such challenges, researchers developed an 'out-of-the-isolator' germ-free condition by extremely controlling the raising and operation of GF mice under a conventional condition (30) . Following the exact procedures, these mice could be kept in GF condition at least for two weeks, thus it became possible to short-termly test large numbers of microbial combinations for phenotype screening in this way (30) . Although still long way to go, by using a single rich medium under anaerobic culture conditions in arrayed-plates, the researchers now could recover approximately a half of the bacteria (97% of ID operational taxonomic units, OTUs) at species-level taxonomy from human fecal samples (31) (Figure 1) .
By integrating different approaches, researchers achieve many mechanistic understanding of how symbiotic effector strains shape our immune system for preventing infectious diseases and other inflammatory disorders.
Induction of Th17 cells in the intestine
Th17 cells, which produce effector cytokines IL-17, IL-17F, IL-21, and IL-22, are critical for intestinal mucosal immunity. Differing to classic Th1/2 lineages, the developmental fate of Th17 lineage is more plastic and is controlled by a distinct group of cytokines and transcription factors. In naïve T cells, after T-cell antigen receptor (TCR) activation, TGF-β and IL-6 induce the expression of Th17-polarized transcription factors retinoid-related orphan receptor α and γt (RORα and RORγt) by activating Smads and STAT3 respectively (32). Other cytokines, such as IL-21, IL-23, and IL-1β then cooperatively drive the terminal differentiation of Th17 cells by distinct mechanisms (32). Both Il17a-and Il22-deficient mice were susceptive to either dextran sulfate sodium (DSS)-induced colitis or Citrobacter rodentium infection, indicating that Th17 cells have a protective role during intestinal mucosal immunity by releasing those two cytokines (33-37). Even in steady status, Th17 cells were remarkably accumulated in the lamina propria (LP) region of intestine in specific-pathogen free (SPF) mice. However, Th17 cells were greatly reduced in the LP of either germ-free (GF) mice or antibiotic-treated mice, suggesting that the generation of intestinal Th17 cells are influenced by symbiotic microbes (38,39). GF mice also exhibited much lower luminal adenosine 5′-triphosphate (ATP) concentration than that of SPF mice (38). Restorations of ATP into these GF mice resulted in a remarkable induction of Th17 cells in the LP region by activating dendritic cells, indicating that commensal-derived ATP can induce intestinal Th17 cells during steady status (38)
with microbial signals by pattern recognition receptors (PRRs) and subsequently produced IL-6 and TGF-β to generate effector Th17 cells in the gut (40).
Compared with SPF mice from Taconic Farms, the same genetic background SPF mice from Jackson Laboratory showed remarkable reduction of LP Th17 cells, indicating that environmental factors such as microbiota may vary between different facilities and such variations may account for the different Th17 frequencies observed in the gut (39). Indeed, following study showed that one gut bacterium, SFB, was required for intestinal Th17 cells induction during steady condition (29) . SFB were indigenous spore-forming gut resident bacteria and are most closely related to the bacteria in Clostridium genus (41). Those bacteria adhered tightly to intestinal epithelium where their existence has been noticed to correlate with the limited flourish of intestinal pathogens (42,43). Restoration of SFB in Th17 cells-lacking mice rebooted the Th17 responses in the small intestine of those mice (29) . The study also showed that the induction of Th17 cells in the gut did not require TLR, NOD, and ATP-mediated signalings, but was dependent on the serum amyloid A (SAA)-mediated pathways (29) . More recently, one study showed that SFB could be co-cultured with intestinal epithelial cells in vitro. In this system, SFB could attach to the intestinal epithelial cells from both mouse and human and could rearrange actin in those cells (44). In addition, SFB induced the expression of antibacterial and inflammatory genes including SAAs in those cells (44). SAA proteins then signaled through dendritic cells to induce the production of IL-6 and IL-23, which are critical for Th17 cells differentiation (29, 45) . A latest study found that host-specific adhesion of SFB was necessary for host-specific induction of intestinal Th17 cells (46). This study also pointed out that ILC3-derived IL-22 and CD11c + cell-derived IL-1β were critical for the production of SAAs in intestinal epithelial cells, SAAs, in turn stimulated IL-1β expression in CD11c + cells to promote Th17 cell differentiation in the gut (46). Besides, the authors demonstrated that intestinal epithelial cell-derived reactive oxygen species (ROS) could enhance Th17 frequencies in the gut, although the mechanism behind was still not clear (46). Thus, upon SFB adhesion, the interplay of intestinal epithelial cells, dendritic cells, and innate lymphoid cells may generate a complex signaling network for constitutive induction of Th17 cells in the LP (Figure 2 and Table 1 ).
In addition to epithelium-derived SAAs and ROS, antigens derived from SFB, which are presented by intestinal dendritic cells in a major histocompatibility complex class II (MHCII)-dependent manner, were required for the induction of Th17 cells (47). In SFB-colonized mice, the TCR repertoire of Th17 cells differed from that of other CD4 + T cells and most Th17 cells recognized SFB antigens in the gut (47,48). Even in the SFB-colonized mice infected with Listeria monocytogenes, a strong inducer of Th1 responses, the majority of Th17 cells was still specific to recognize SFB antigens, indicating that the specificity of effector T cells is determined by the type of bacteria (48). It was reported that the intrinsic MHCII in ILC3s could limit the frequency of commensal bacteria specific
CD4
+ T cells by triggering the apoptosis of those cells in the gut (49,50). Indeed, mice lacking MHCII in ILC3s had an increase of Th17 cells even in the absence of SFB, which disagreed with the previous study (49), the authors did not observe any spontaneous intestinal inflammation in those mice (47). Thus, MHCII molecules in dendritic cells and ILC3s discriminatively regulate intestinal Th17 cell development.
It was likely that mice colonized with SFB were susceptible to autoimmune diseases such as autoimmune arthritis and encephalomyelitis, indicating that colonization of SFB in the gut may promote harmful inflammation in other remote organs (51, 52) . However, in the intestine, once SFB colonized the epithelium, mice were protected from the intestinal pathogen Citrobacter rodentium infection, as Th17-derived IL-17 and IL-22 induced the expression of antibacterial and tissue repairing genes in the gut (29, 34, 37) . SFB also prevented the colonization and growth of enteropathogenic E.coli O103 in rabbit gut (43). This host resistance to the pathogens infection, induced by SFB colonization, is also a good illustration of symbionts-mediated defenses against intestinal pathogens. Extracellular pathogens, on the other hand, also adhered to epithelium to induce inflammatory Th17 responses during infection (46). Loss of epithelium adhesion ability in Citrobacter rodentium and enteropathogenic E.coli O103 largely impaired the intestinal Th17 responses induced by those pathogens (46). In human, transplantation of fecal samples from either health donors or colitis patients into GF mice could induce Th17 cell accumulation in the gut of those mice, although different bacteria species were likely to account for the Th17 cell induction in mice colonized with bacteria from different donors (46). The authors further identified 20 bacterial strains, which were isolated from fecal sample of a colitis patient by anaerobic culture, with great Th17 cell induction capacity in both GF mice and rats (46). Those bacteria, similar to SFB, could adhere to intestinal epithelial cells, indicating that the adhesion of specific gut bacteria may be essential for the induction of Th17 cells in the gut (46) (Figure 2 and Table 1 ).
Induction of Treg cells in the intestine
Treg cells are highly suppressive CD4 + T cells that are critical for the immune tolerance for self-antigens and the prevention of over-activated immune responses (eg., in- fection induced-endotoxin shock) which are harmful to host (53) . CD4 + Treg cells are classified into two major subsets: natural Tregs (nTregs), which are derived from the thymus, and induced Tregs (iTregs), which originate from the periphery (53) . The differentiation of Treg cells is controlled by TGF-β signaling and transcription factor Foxp3 (53). Compared to Tregs from the thymus, the peripheral induced Tregs had low expression of Helio and Neuropilin-1, and these Helio -Neuropilin-1 -Foxp3 + Treg cells were extremely abundant in the LP of intestine (54) (55) (56) . In GF or antibiotic-treated mice, the colonic but not small intestinal Helio -Neuropilin-1 -Foxp3 + Treg cells were greatly reduced, indicating that the mucosal Treg cells in the colon and small intestine are regulated by distinct mechanisms (56) . An early study showed that, a probiotic bacterial strain, Lactobacillus reuteri, induced Treg cells when it was administrated into mice, however, many probiotics were not long-term resident microbes in our gut, thus these bacteria were unlike to be the stable inducers of the intestinal Treg cells (57) . Another study showed that mice fed with Bifidobacterium infantis were resistant to Salmonella typhimurium infection by the accumulation of both mucosal and splenic Treg cells (58) . However, those studies cannot show direct evidences that a certain bacterium is specific for intestinal Treg induction, as delivery of such bacterium may have certain influence on resident symbionts thus indirectly modulates Treg cell accumulation in the gut. Recently, a human commensal, Bacteroides fragilis, was shown that could direct colonic Treg cell maturation by boosting IL-10 production in these cells (17, 59) . A B.fragilis capsule component, polysaccharide A (PSA), induced the expression of IL-10 by directly signaling through TLR2 on CD4 + T cells (17, 59) . The authors also showed that PSA could prevent, even cure experimental colitis in mice (17, 59) (Figure 2 and Table 1) .
By applying a selective approach in a larger scale, following study showed that clusters IV and XIVa of the genus Clostridium strongly induced colonic Treg cells in LP (56) . The authors isolated 46 strains of Clostridium from chloroform-treated fecal samples, which contain abundant spore-forming bacteria (56) . Colonization of these strains in GF mice generated a TGF-β-rich environment, thus greatly increased the frequency of Treg cells in the colon (56) . In combination with the sequencing technology, the same group also identified 17 strains of Clostridium from chloroform-treated fecal materials donated by health peoples (60) . These 17 strains belonged to clusters IV, XIVa, and XVIII of Clostridium and were able to induce Treg cell accumulation in the colon when introduced into GF mice and rats. However, individual-colonization of these bacteria could not induce Treg cells in the colon of GF mice, indicating that the interplay of Clostridium community is required for Treg induction in vivo (60) . Both the mouse-and human-derived communities of Clostridium were able to prevent mice from colitis or allergy when they are introduced (56, 60) . In the previous studies, researchers used chloroform, which may be harsh to many gut bacteria, to isolate members in Clostridium. This biased selection may neglect certain strains with Treg-induction capacity in the intestine. More recently, by using an unbiased-anaerobic culture approach, one study identified several strains of Bacteroides from health donors were able to induce Treg cells in the colon (30) . Unlike the synergistic effect of the 17 strains of Clostridium, mono-colonization of individual-isolated Bacteroides could sufficiently induce Treg cells in the colon of GF mice (30) . The study also noted that that E.coli could moderately induce colonic Treg cells (30) (Figure 2 and Table 1) .
Mechanically, recent studies demonstrated that shortchain fatty acids (SCFAs), gut commensal-derived bacterial fermentation metabolites, induced the differentiation of colonic Treg cells by several ways. SCFAs, particularly butyrate, could directly induce Treg accumulation by inhibiting histone deacetylases (HDACs), which constitutively suppressed histone H3 acetylation of the enhancer of Foxp3 gene in T cells (61, 62) . In addition, T cell-intrinsic G protein coupled receptor (GRP) 43 signaling might affect Treg cell induction through HDACs inhibition (63) . Besides to T cells, SCFAs also affected other cell populations to indirectly promote the development of Treg cells in the gut. SCFAs suppressed dendritic cell functions by inhibiting inflammatory genes expression in these cells, thus favoring Treg accumulation (61) . SCFAs also signaled through GPR109a to induce anti-inflammatory genes expression in these cells (64) . In addition to dendritic cells, SCFAs could activate TGF-β1 production in intestinal epithelial cells, thus contributed to differentiation of Treg cells in the gut (60) . Colonization of GF mice with human-derived Bacteroides also led to increases in cecal SCFAs, indicating that SCFAs may also contribute to Treg accumulation in these mice (30) . (Figure 2 and Table 1) Similar to Th17 cells, colonic Tregs cells also displayed specific TCRs to intestinal microbes. The TCRs of colonic Treg cells differed from those of Treg cells in other locations, implying that local antigens such as those from commensal microbiota are required for shaping Treg population in the colon (65) . In the case of Clostridia-induced Treg cells, the authors indeed showed that some of colonic Treg cells in 17 strains of Clostridia-colonized GF mice were specific to the antigens from those bacteria (60). (Figure 2) However, a recent study demonstrated that the generation of intestinal Treg cells was independent of MHCII, implying that some of Treg cells in the gut may be induced in an antigen-independent way (66) .
Conclusion
The human body coevolves with complex symbiotic bacterial communities that colonize the intestine. The intestinal resident-microbiota is pivotal for host nutrients absorption and energy balance, on the other hand, it educates the host immune system even at the beginning of life for preventing us from infectious diseases. Impeded by technical obstacles, for a long time, the functional roles of microbes living in our gut are less defined. Technological advances such as high through-put sequencing, anaerobic culture, and germ-free animal models largely improve our understanding of the interactions between the gut microbiota and the host mucosal system. The discoveries of effector strains for intestinal Th17 and Treg cell induction are 'classic' illustrations of how symbiotic bacteria tune the immune system against intestinal infectious diseases or other inflammatory disorders. By integration of these systematic approaches, we may decipher the mechanisms hiding behind these complex microbial communities, thus to recapitulate the entire microbial diversity and develop new diagnostic and therapeutic strategies to benefit human health in the future. 
